Pre-clinical studies more...human

Human iPSCs-derived neurons

Animal-to-human data translation is particularly poor in CNS-related pharma development.

We propose to use human neurons at preclinical stages to  ensure data reliability an limit the risk of failure.

  • IPSC-derived neurons are a relevant model in the assessment of safety and efficacy profiles of compounds.

  • In some cases, the cells may come from patient carrying a specific mutation of interest for several pathologies.

  • IPSCs can be differentiated into the most comon cell types (glutamatergic, gabaergic, dopaminergic, motor etc.)

  • Patch-clamp recordings do not take longer than on tissues from rodents.

  • Results become far more predictive.


Rodent acute slices

We provide dissociated cultures as well as acute slice recordings from rodents. These easy-to-use preparations present various advantages.

  • All circuits are intact and all cell types are present.

  • Alteration of circuit-specific phenomena can be studied: plasticity, gamma-oscillations, epilepsy etc.


  • Transgenic mouse models reliably mimic human pathologies.

  • Precise manipulations (e.g. cell-type-specificity, knock-out, optogenetics etc.) can easily be achieved by employing transgenic animals.



We partner with an on-site innovative company providing state of the art in vivo recordings and behavior analysis to complement our in vitro approach. 

  • Recordings can be done in anaesthetized or freely-moving animals

  • After implantation of the recording electrodes, single and multi-units are obtained.


  • Top-quality behavioral testings and analysis are also available.

  • All experiments are designed and performed by experts in the field.